Actively Recruiting
Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)
Led by Institut Claudius Regaud · Updated on 2025-07-31
105
Participants Needed
1
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Interventional, prospective, single-centre study aimed to evaluate the impact of a video-assisted remote speech therapy consultation in relation to the complexity and specificity of the care of patients with ORL cancer. Three indications will be studied: phonation problems, swallowing problems and other problems. The study will be conducted on a population of patients with T3, T4 ORL cancer requiring speech therapy. Each patient included will have a video-assisted speech therapy consultation with a private speech therapist and an expert speech therapist. At the end of this video consultation, the patient and the private speech therapist will be asked to complete a satisfaction questionnaire. At the follow-up visit following the video-assisted consultation, the patient will have completed participation in the study.
CONDITIONS
Official Title
Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older at study entry
- Diagnosed with cancer of the upper aerodigestive tract (VADS) relevant to surgery, radiotherapy, or chemotherapy
- Managed at the IUCT-O center and by a private speech therapist near the patient's home
- Affiliated with a Social Security system in France
- Signed informed consent before joining the study and any study procedures
You will not qualify if you...
- Pregnant or lactating women
- Psychological, familial, geographical, or sociological conditions preventing compliance with medical follow-up or study procedures
- Patients deprived of liberty or under legal protection such as guardianship, tutorship, or safeguard of justice
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Institut Universitaire du Cancer de Toulouse - Oncopole
Toulouse, France
Actively Recruiting
Research Team
J
Jérôme SARINI
CONTACT
J
Jean-Claude FARENC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here